Register through Sept. 17 to receive the lowest rates for Advancing Gene + Cell Therapies for Cancer.
Browse and view ASGCT's viral vector-focused content on-demand. This resource is made available exclusively for ASGCT members.
ASGCT membership unlocks incredible discounts and on-demand access to a rich archive documenting the history of cell and gene therapy. Take the next step in your career by becoming an ASGCT member.
Join
July 9, 2021 This event begins with a short introduction to gene therapy and continues into a very structured approach to AAV vectors. The AAV material presented begins at a basic level but ultimately progresses to a level where mid-career professionals feel very comfortable and early professionals are developmentally pushed. 🔒
August 18, 2021 During this virtual roundtable, experts discussed the status of AAV integration research, including analysis of recent clinical findings, to develop recommendations for risk assessment. 🔒
February 16, 2022 During this session, speakers discuss cutting-edge concepts and methods in the design and development of AAV vectors. Individual presentations are followed by a panel discussion where the invited experts will be available to answer questions from attendees and opine about personal experience and perspectives in the field. 🔒
April 14, 2023 Dr. Phil Tai provides an introduction to gene therapy and then continues into a very structured approach to AAV vectors. 🔒
January 24-25, 2023 Topics during this two-day event include appropriateness and utility of a companion diagnostic for assessing pre-existing immunity, requirements for immunogenicity testing, and more. 🔒
November 30, 2022 This session provides updates on the humoral and cellular immune responses, including the impact of vector design, purity, and dose; DRG toxicity and potential immunological mechanisms; and management of immunological responses with a focus on the nervous system and implications for re-dosing. 🔒
April 28, 2022 We often hear that gene therapies are complex and require a lot of time and money to make. But what does that really mean? Tune in to hear experts in the field help answer this question by walking us through the manufacturing process. 🔒
October 17, 2023 Join ASGCT's expert panel to discover cutting-edge technologies and assays for integration site profiling, clonality, and oncogenesis. 🔒
March 30, 2023 Dr. Lauriel Earley discusses defective-interfering particles and their potential impact on gene therapy outcomes, NGS methods to characterize DI particples, and a case study of an NGS pipeline for AAV. 🔒
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico